Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?

Audrey Benyamine; Daniel Bertin; Xavier Heim; Brigitte Granel; Nathalie Bardin

doi:10.1016/j.ejim.2017.07.033

Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?

Eur J Intern Med. 2017 Oct:44:e42-e44. doi: 10.1016/j.ejim.2017.07.033. Epub 2017 Aug 7.

Authors

Audrey Benyamine¹, Daniel Bertin², Xavier Heim², Brigitte Granel³, Nathalie Bardin⁴

Affiliations

¹ Aix Marseille University, INSERM, VRCM, UMR_S 1076, Marseille, France; APHM, Hôpital Nord, Médecine interne, Marseille, France. Electronic address: Audrey.benyamine@ap-hm.fr.
² APHM, Hôpital La Conception, Laboratoire d'Immunologie, Marseille, France.
³ Aix Marseille University, INSERM, VRCM, UMR_S 1076, Marseille, France; APHM, Hôpital Nord, Médecine interne, Marseille, France.
⁴ Aix Marseille University, INSERM, VRCM, UMR_S 1076, Marseille, France; APHM, Hôpital La Conception, Laboratoire d'Immunologie, Marseille, France.

PMID: 28781194
DOI: 10.1016/j.ejim.2017.07.033

No abstract available

Keywords: Anti-RNA polymerase III antibodies; Anti-centromere antibodies; Anti-topoisomerase I antibodies; Immunofluorescence pattern; Systemic sclerosis.

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Antinuclear / analysis
Antibodies, Antinuclear / blood*
Centromere / immunology
DNA Topoisomerases, Type I / immunology
Female
Fluorescent Antibody Technique
Humans
Male
Middle Aged
RNA Polymerase III / immunology
Retrospective Studies
Scleroderma, Systemic / blood*
Scleroderma, Systemic / immunology

Substances

Antibodies, Antinuclear
RNA Polymerase III
DNA Topoisomerases, Type I